Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Health Catalyst (HCAT) Interest & Investment Income (2023 - 2026)

Health Catalyst filings provide 4 years of Interest & Investment Income readings, the most recent being -$4.1 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 23.21% to -$4.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$17.2 million, a 239.79% decrease, with the full-year FY2025 number at -$16.4 million, down 2675.2% from a year prior.
  • Interest & Investment Income hit -$4.1 million in Q1 2026 for Health Catalyst, up from -$4.6 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.6 million in Q4 2023 to a low of -$4.7 million in Q3 2025.
  • Median Interest & Investment Income over the past 4 years was -$1.5 million (2024), compared with a mean of -$830461.5.
  • Biggest five-year swings in Interest & Investment Income: soared 30.4% in 2024 and later plummeted 261.08% in 2025.
  • Health Catalyst's Interest & Investment Income stood at $2.6 million in 2023, then plummeted by 197.4% to -$2.5 million in 2024, then tumbled by 79.2% to -$4.6 million in 2025, then increased by 9.44% to -$4.1 million in 2026.
  • The last three reported values for Interest & Investment Income were -$4.1 million (Q1 2026), -$4.6 million (Q4 2025), and -$4.7 million (Q3 2025) per Business Quant data.